CEO exercised or converted 8,009 RMD derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Oct 7, 2025
- Reporting period
- Not applicable
- Filed with the SEC
- Oct 9, 2025
CEOOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000943819-25-000086
Added to OQROOct 2, 2026, 12:28 PM UTC Data qualityVerified: identifiers matched exactly Reporting personMichael J. Farrell Officer titleChief Executive Officer SecurityResMed Common Stock Options TableDerivative (Table II) Transaction dateOct 7, 2025 Acquired / disposedDisposed (D) Footnotes from the filing
- Represents date options first become exercisable. Options vest 1/3 per year.
Around the same time
Derivative exercise or conversion — not an open-market buy.
CFO sold ~$743K of ResMed|
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.